Isabella, Gruber http://orcid.org/0000-0002-7435-9337
Katharina, Appel
Matthias, Edinger
Oliver, Koelbl
Daniel, Wolff
Funding for this research was provided by:
Universitätsklinikum Regensburg
Article History
Received: 3 February 2024
Accepted: 2 March 2024
First Online: 22 March 2024
Declarations
:
: Gruber Isabella, Appel Katharina, Koelbl Oliver and Edinger Matthias have no financial or non-financial interests to disclose. Wolff Daniel received research support from Novartis and honoraria from Novartis, Sanofi, Incyte, Behring, Neovii, Takeda and Mallinckrodt.
: Gruber Isabella, Appel Katharina, Koelbl Oliver and Edinger Matthias have no financial or non-financial interests to disclose. Wolff Daniel received research support from Novartis and honoraria from Novartis, Sanofi, Incyte, Behring, Neovii, Takeda and Mallinckrodt.
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Regensburg (number, 20-1810-101, date, February 10, 2021).
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.